Dr. Isaacs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10201 Carnegie Ave
Cleveland, OH 44106Phone+1 866-223-8100
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2019 - 2022- Duke University HospitalResidency, Hematology and Medical Oncology, 2016 - 2022
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2016
Certifications & Licensure
OH State Medical License 2022 - 2026
NC State Medical License 2016 - 2022
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis.Cameron Wood, Liliana Lyniv, James M Isaacs, Jacob M Kaufman, Eziafa I Oduah
Journal for Immunotherapy of Cancer. 2025-02-04 - Real-world outcomes of patients with resected stage III melanoma treated with adjuvant therapies.Danai Dima, Nerea Lopetegui-Lia, Olisaemeka Ogbue, Bennett Osantowski, Fauzia Ullah
Cancer Medicine. 2024-06-01 - 18 citationsTranscriptional and epigenetic regulators of human CD8T cell function identified through orthogonal CRISPR screens.Sean R McCutcheon, Adam M Swartz, Michael C Brown, Alejandro Barrera, Christian McRoberts Amador
Nature Genetics. 2023-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
